JLK "Additional Stroke Solutions... Multiple Non-Covered Services Awaiting Approval"
JL-K announced on the 30th that it is actively working to ensure that all 11 full-package solutions addressing the entire stroke care cycle, starting with JBS-01K, which is classified as a non-reimbursable item, can be utilized in medical settings.
The Ministry of Health and Welfare announced on the 26th the first domestic health insurance reimbursement application for artificial intelligence (AI) medical devices. As the first case, JL-K's AI cerebral infarction classification solution ‘JBS-01K’ was selected, marking the beginning of a new era of AI medical devices.
Currently, the AI hemorrhagic stroke analysis solution ‘JBS-04K’, cerebral aneurysm detection solution ‘JBA-01K’, and early detection of cerebral vascular occlusion ‘JBS-LVO’ are undergoing integrated review and evaluation as innovative medical devices. Additionally, seven other solutions are also preparing for non-reimbursable status in sequence.
Hot Picks Today
"Could I Also Receive 370 Billion Won?"... No Limit on 'Stock Manipulation Whistleblower Rewards' Starting the 26th
- Samsung Electronics Labor-Management Reach Agreement, General Strike Postponed... "Deficit-Business Unit Allocation Deferred for One Year"
- "From a 70 Million Won Loss to a 350 Million Won Profit with Samsung and SK hynix"... 'Stock Jackpot' Grandfather Gains Attention
- "Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
The additional solutions in progress are expected to be applied with different non-reimbursable fees respectively. The solid lineup of more than 11 stroke-related solutions held by JL-K is expected to significantly contribute to future sales.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
